Xiaojin capsule versus combined norethisterone acetate treatment for endometriosis-associated deep dyspareunia- a prospectively randomized controlled trial: Effect on pain during intercourse and sexual satisfactio

Not Applicable

Recruiting

• Conditions: endometriosis-associated deep dyspareunia

• Registration Number: ITMCTR2100004287
• Lead Sponsor: Zhejiang Provincial People's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Subjects with persistent endometriosis-associated deep dyspareunia, with or without dysmenorrhea for more than 3 months.

Exclusion Criteria

1.obstructive uropathy or symptomatic bowel stenosis;
2.evidence of complex adnexal cysts or an ovarian endometrioma of diameter more than 4 cm at vaginal ultrasonography; 3.therapies for endometriosis other than non-steroidal anti inflammatory drugs (NSAIDs) in the 3 months before study entry (6 months for GnRH analogues);
4.the typical contraindications to progestins;
5.the use of drugs that interfere with ovarian steroid metabolism;
6.allergy to components of the study medication;
7.abnormal findings at breast examination and mammary ultrasound scan;
8.an abnormal cervical smear;
9.a diagnosis of concomitant pelvic inflammatory disease, pelvic varices or genital malformations at previous surgery; 10.known gastrointestinal, urologic and orthopedic diseases;
11.psychiatric disturbances;
12.history of drug or alcohol abuse.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
pain evaluation;sexual functioning questionnaire;